Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04475497 · ClinicalTrials.gov registry record · NA

Role of Blood Management in Perioperative Outcomes

A NA study, sponsored by The Cleveland Clinic.

Terminated
Registry status
NA
Development phase
18
Enrollment target

NCT04475497 is a NA study that was terminated before completion, run by The Cleveland Clinic. The registered enrollment target is 18 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04475497, a NA study, was terminated before completion, sponsored by The Cleveland Clinic.

TERMINATED
Registry status
NA
Development phase
18 participants
Enrollment target

Study Summary

There is currently limited information regarding the role of blood management in the benign gynecologic population and specifically, in patients who are scheduled to undergo surgery for fibroids and/or abnormal uterine bleeding. A thorough search through PubMed and clinicaltrials.gov did not reveal any studies on this issue. In 2019 at CCF only 2% of gyn patients at Main Campus were referred to blood management, but 12.6% of the main campus gyn population had a Hb of \<10.0 g/dL. The overall goal of this study is to evaluate the role of preoperative blood management in optimizing surgical outcomes by reducing the co-morbidities associated with postoperative blood transfusion.

Interventions

  • OTHER Usual care
  • OTHER Blood management

Trial Details

FieldValue
Enrollment Target 18 participants
Start Date 2020-07-24
Est. Completion 2023-05-18
Phase NA

Sponsor

The Cleveland Clinic

688 total trials

What the Registry Record Tells You About NCT04475497

The ClinicalTrials.gov registry entry for NCT04475497 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 18 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is The Cleveland Clinic, which has 688 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which Usual care is the first listed.

NCT04475497 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT04475497 about?

NCT04475497 is a clinical study titled "Role of Blood Management in Perioperative Outcomes". There is currently limited information regarding the role of blood management in the benign gynecologic population and specifically, in patients who are scheduled to undergo surgery for fibroids and/or abnormal uterine bleeding. A thorough search through PubMed and clinicaltrials.gov did not reveal ...

What is the current status of trial NCT04475497?

This trial is currently terminated. It is a NA study. The enrollment target is 18 participants. The study started on 2020-07-24. Estimated completion is 2023-05-18.

What interventions are being tested in trial NCT04475497?

The interventions under investigation include: Usual care (OTHER), Blood management (OTHER).

Who is sponsoring clinical trial NCT04475497?

This trial is sponsored by The Cleveland Clinic, which has 688 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.